Equity Overview
Price & Market Data
Price: $0.685
Daily Change: -$0.0155 / 2.26%
Daily Range: $0.65 - $0.685
Market Cap: $552,674,432
Daily Volume: 6,500
Performance Metrics
1 Week: -1.60%
1 Month: -13.85%
3 Months: -8.73%
6 Months: -0.57%
1 Year: -38.33%
YTD: -16.52%
Company Details
Employees: 301
Sector: Health technology
Industry: Biotechnology
Country:
Details
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.